Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q1 2026 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2026-04-21

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: Apr 21, 2026

Total Value: $982M (100.0% shares, 0.0% debt)

Holdings (4)

CNTA CENTESSA PHARMACEUTICALS PLC 80.8%

Value $793M Shares 19,963,157 Est. Cost $20.88 Unrealized —

NAMS NEWAMSTERDAM PHARMA COMPANY 8.7%

Value $85.6M Shares 2,674,182 Est. Cost $10.96 Unrealized +208.0%

PHAT PHATHOM PHARMACEUTICALS INC 8.4%

Value $82.93M Shares 7,464,572 Est. Cost $13.72 Unrealized -0.2%

AURA AURA BIOSCIENCES INC 2.1%

Value $20.34M Shares 3,039,892 Est. Cost $17.87 Unrealized -69.5%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$793M	80.8%	$20.88	—	SPONSORED ADS	152309100
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,674,182	$85.6M	8.7%	$10.96	+208.0%	ORDINARY SHARES	N62509109
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$82.93M	8.4%	$13.72	-0.2%	COM	71722W107
AURA	AURA BIOSCIENCES INC	3,039,892	$20.34M	2.1%	$17.87	-69.5%	COM	05153U107